Caris & Co

Caris Life Sciences is a leading next-generation AI techbio company and precision medicine pioneer based in Irving, Texas. The company specializes in comprehensive molecular profiling, utilizing Whole Exome and Whole Transcriptome Sequencing to provide clinicians with actionable insights for personalized cancer treatment. Its flagship MI Profile service analyzes DNA, RNA, and proteins to identify biomarkers across all 22,000 genes. Beyond diagnostics, Caris leverages its massive clinico-genomic database and proprietary ADAPT Biotargeting System to accelerate drug discovery through its Caris Discovery arm. The company maintains a vast network of clinical partners through the Caris Precision Oncology Alliance, facilitating collaborative research and clinical trial enrollment. With significant backing from major private equity firms, Caris continues to innovate in liquid biopsy and AI-driven diagnostic signatures.